NextGen Healthcare - NXGN Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NextGen Healthcare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" NXGN shares.
View NXGN analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued 1-year target prices for NextGen Healthcare's stock. Their NXGN share price forecasts range from $20.00 to $26.00. On average, they predict the company's stock price to reach $22.75 in the next year. This suggests a possible upside of 25.9% from the stock's current price.
View analysts price targets for NXGN or view top-rated stocks among Wall Street analysts.

NextGen Healthcare's stock was trading at $18.78 at the beginning of 2023. Since then, NXGN shares have decreased by 3.8% and is now trading at $18.07.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 16th 2023.
View our NXGN earnings forecast.

NextGen Healthcare, Inc. (NASDAQ:NXGN) posted its quarterly earnings data on Thursday, October, 28th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.06. The company had revenue of $149.29 million for the quarter, compared to analyst estimates of $143.47 million. NextGen Healthcare had a net margin of 3.66% and a trailing twelve-month return on equity of 6.41%. The firm's revenue for the quarter was up 6.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.24 EPS.

NextGen Healthcare issued an update on its FY23 earnings guidance on Tuesday, January, 24th. The company provided earnings per share (EPS) guidance of $0.93-0.99 for the period, compared to the consensus EPS estimate of $0.97. The company issued revenue guidance of $642-650 million, compared to the consensus revenue estimate of $639.63 million.

248 employees have rated NextGen Healthcare Chief Executive Officer Rusty Frantz on Glassdoor.com. Rusty Frantz has an approval rating of 72% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other NextGen Healthcare investors own include Altria Group (MO), Verizon Communications (VZ), Exxon Mobil (XOM), Best Buy (BBY), Enbridge (ENB), Enterprise Products Partners (EPD), Huntington Bancshares (HBAN), Netflix (NFLX), Tapestry (TPR) and Twitter (TWTR).

NextGen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

NextGen Healthcare's stock is owned by a number of retail and institutional investors. Top institutional investors include Assenagon Asset Management S.A. (1.28%), Phocas Financial Corp. (0.46%), Mckinley Capital Management LLC Delaware (0.36%), AMH Equity Ltd (0.23%), Yousif Capital Management LLC (0.05%) and Maryland State Retirement & Pension System (0.03%). Insiders that own company stock include Craig A Barbarosh, David A Metcalfe, David Ahmadzai, David William Sides, Donna Cullen Greene, George H Bristol, James Robert Jr Arnold, Jeffrey D Linton, Jeffrey H Margolis, John R Frantz, Lance Rosenzweig, Mitchell Waters, Sean Brynjelsen and Srinivas S Velamoor.
View institutional ownership trends.

Shares of NXGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NXGN stock can currently be purchased for approximately $18.07.

NextGen Healthcare (NASDAQ:NXGN) has a market capitalization of $1.22 billion and generates $596.35 million in revenue each year. The company earns $1.62 million in net income (profit) each year or $0.35 on an earnings per share basis.

The company employs 2,655 workers across the globe.

NextGen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The official website for the company is www.nextgen.com. The company can be reached via phone at (404) 467-1500, via email at ir@nextgen.com, or via fax at 949-255-2605.